Effect of cadmium or magnesium on calcium-dependent central function that reduces blood pressure

Arch Toxicol. 2000 Mar;74(1):1-4. doi: 10.1007/s002040050644.

Abstract

The effect of intracerebroventricular (i.c.v.) administration of cadmium or magnesium on central calcium-dependent blood pressure regulation was investigated. The systolic blood pressure of spontaneously hypertensive rats (SHR; male, 13 weeks of age) decreased following i.c.v. administration of cadmium chloride (20 nmol/rat), and increased following i.c.v. administration of magnesium chloride (20, 600, and 1,200 nmol/rat). The hypotensive effect of cadmium was suppressed by i.c.v. administration of W-7 (a calmodulin antagonist, 30 microg/rat). Taking into consideration these results with our previous reports, it is suggested that cadmium binds to the calcium-binding sites of calmodulin and activates calcium/calmodulin-dependent enzymes in a disorderly manner, whereas magnesium does not. Therefore, cadmium increases dopamine synthesis in the brain via a calmodulin-dependent system, and the resultant increase in dopamine levels inhibits sympathetic nerve activity and reduces blood pressure in SHR.

MeSH terms

  • Animals
  • Blood Pressure / drug effects*
  • Cadmium / administration & dosage
  • Cadmium / antagonists & inhibitors
  • Cadmium / pharmacology*
  • Calcium / physiology*
  • Calcium-Calmodulin-Dependent Protein Kinases / antagonists & inhibitors
  • Central Nervous System / drug effects
  • Central Nervous System / physiology*
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Infant
  • Injections, Intraventricular
  • Magnesium / administration & dosage
  • Magnesium / antagonists & inhibitors
  • Magnesium / pharmacology*
  • Male
  • Rats
  • Rats, Inbred SHR
  • Sulfonamides / pharmacology

Substances

  • Enzyme Inhibitors
  • Sulfonamides
  • Cadmium
  • W 7
  • Calcium-Calmodulin-Dependent Protein Kinases
  • Magnesium
  • Calcium